Attention deficit hyperactivity disorder: guidelines for investigating efficacy of pharmacological intervention.
Buitelaar
J K
JK
Montgomery
S A
SA
van Zwieten-Boot
B J
BJ
D000293:Adolescent; D000367:Age Factors; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D002648:Child; D002675:Child, Preschool; D002985:Clinical Protocols / Q000592:standards*; D015897:Comorbidity; D039721:Diagnostic and Statistical Manual of Mental Disorders; D004304:Dosage Forms / Q000592:standards; D006801:Humans; D007360:Intelligence; D038801:International Classification of Diseases / Q000592:standards; D018579:Patient Selection; D012107:Research Design / Q000592:standards; D012720:Severity of Illness Index; D016896:Treatment Outcome
D000928:Antidepressive Agents; D004304:Dosage Forms